08/28/2022
Minority patients are not participating in clinical trials because they do not trust the medical community, and FDA has noted the lack of diversity and inclusion of patients in clinical trials. In this interview, Patrice Matchaba, MD, President of Novartis US Foundation, created The Beacon of Hope, the first Clinical Trial Center of Excellence focusing on building bridges between clinical trials and minority communities, will discuss how the biopharmaceutical industry can regain the trust of minorities.
In this interview, Patrice Matchaba, MD, President of Novartis US Foundation discusses how the biopharmaceutical industry can regain the trust of minorities....